Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer Research

• Publication date

  1993-01-15

• Fields of study

  Medicine

• Identifiers
  PMID 8417826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis inhibition by minocycline.

  1991cited by this paper
• Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema.

  1991cited by this paper
• Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.

  1991cited by this paper
• Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate

  1990cited by this paper
• New methods of drug delivery.

  1990cited by this paper
• Brain biocompatibility of a biodegradable, controlled-release polymer in rats.

  1989cited by this paper
• Intracerebral drug delivery in rats with lesion-induced memory deficits.

  1989cited by this paper
• Controlled release of dopamine from a polymeric brain implant: In vivo characterization

  1989cited by this paper
• Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.

  1989cited by this paper
• Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation.

  1989cited by this paper
• Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.

  1988cited by this paper
• Chemotherapy for malignant gliomas.

  1988cited by this paper
• Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity.

  1986cited by this paper
• Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.

  1985cited by this paper
• Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics.

  1985cited by this paper
• Improved treatment of a brain-tumor model. Part 1: Advantages of single- over multiple-dose BCNU schedules.

  1983cited by this paper
• Bioerodible polyanhydrides for controlled drug delivery.

  1983cited by this paper
• Zero-order controlled-release polymer matrices for micro- and macromolecules.

  1983cited by this paper
• Biocompatibility of polymeric delivery systems for macromolecules.

  1981cited by this paper
• Growth and Chemotherapeutic Response in Athymic Mice of Tumors Arising from Human Glioma‐derived Cell Lines

  1981cited by this paper
• Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics.

  1980cited by this paper
• Assumptions in the radiotherapy of glioblastoma

  1980cited by this paper
• Rational planning of brain tumour therapy based on laboratory investigations: comparison of single- and multiple-dose BCNU schedules.

  1980cited by this paper
• Blood-brain barrier: a definition of normal and altered function.

  1980cited by this paper
• Chemotherapy of human tumor xenografts in genetically athymic mice.

  1978cited by this paper
• Polymers for the sustained release of proteins and other macromolecules

  1976cited by this paper
• Chemotherapeutic implications of early tumor cell growth in an animal brain-tumor model.

  1975cited by this paper
• Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.

  1973cited by this paper
• Morphological studies of rat brain tumors induced by N-nitrosomethylurea.

  1971cited by this paper
• Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture.

  1971cited by this paper
• Lewis's pharmacology

  1970cited by this paper
• Mechanisms of Drug Absorption and Excretion

  1964cited by this paper
• Mechanisms of Drug Absorption and Excretion Passage of Drugs in and out of the Central Nervous System

  1962cited by this paper
• An Experimental Method for Comparing Treatments of Intact Malignant Tumours in Animals and its Application to the Use of Oxygen in Radiotherapy

  1960cited by this paper
• THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE

  1940cited by this paper

• Manufacturing and testing of a polymer formulation for long-time release delivery of antisense oligonucleotides in hiPSC-derived motoneurons

  2026cites this paper
• Research as an Imperative for Clinical Excellence

  2025cites this paper
• Evaluation of blood-tumor barrier permeability and doxorubicin delivery in rat brain tumor models using additional focused ultrasound stimulation

  2025cites this paper
• Ultrasound inhibits tumor growth and selectively eliminates malignant brain tumor in vivo

  2024cites this paper
• The Current Status and Prospects of Poly(Lactic Acid) Applications in Clinical Treatment

  2024cites this paper
• Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma

  2024cites this paper
• Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation.

  2024cites this paper
• Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives

  2024cites this paper
• Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients

  2023cites this paper
• Long-Acting Therapeutic Delivery Systems for the Treatment of Gliomas.

  2023cites this paper
• Application of Biomaterials for Glioblastoma Treatment: Promises, Advances, and Challenges

  2022cites this paper
• Supramolecular Hydrogel Based Post-Surgical Implant System for Hydrophobic Drug Delivery Against Glioma Recurrence

  2022cites this paper
• Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.

  2021cites this paper
• Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: A Review

  2021cites this paper
• Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?

  2021influential citation
• Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma

  2021cites this paper
• Targeting to the CNS: Approach for brain tumor

  2021cites this paper
• Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches

  2020cites this paper
• Advances in local and systemic drug delivery systems for post-surgical cancer treatment.

  2020cites this paper
• Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy.

  2020cites this paper
• Neurosurgical Implant-Based Strategy for Brain Cancer Therapy

  2020cites this paper
• Novel therapeutics for brain tumors: current practice and future prospects

  2020cites this paper
• Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.

  2020cites this paper
• Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far

  2019cites this paper
• Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste

  2019cites this paper
• Pharmacokinetics of Polymeric Drug Delivery

  2019cites this paper
• Advances in drug delivery for post-surgical cancer treatment.

  2019cites this paper
• Drug-Impregnated Polymer Delivery

  2019cites this paper
• Brain local delivery strategy

  2019cites this paper
• Progress in Clinical Application of Carmustine

  2018cites this paper
• Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats

  2018cites this paper
• Drug delivery systems for programmed and on‐demand release☆

  2018cites this paper
• Targeted Local Therapy for Management of Intracranial High-Grade Gliomas.

  2018cites this paper
• Developing Therapies for Brain Tumors: The Impact of the Johns Hopkins Hunterian Neurosurgical Research Laboratory.

  2017cites this paper
• Redox‐Activatable ATP‐Depleting Micelles with Dual Modulation Characteristics for Multidrug‐Resistant Cancer Therapy

  2017cites this paper
• Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer

  2017cites this paper
• Current Standard Treatment Options for Malignant Glioma

  2017cites this paper
• Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.

  2017cites this paper
• Polylactic acid (PLA) controlled delivery carriers for biomedical applications.

  2016cites this paper
• Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes.

  2016cites this paper
• Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).

  2016cites this paper
• Chitosan-functionalized poly(lactide-co-glycolide) nanoparticles: breaking through the brain’s tight security gateway

  2016cites this paper
• Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.

  2016cites this paper
• Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors

  2016cites this paper
• Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM

  2016cites this paper
• Mechanisms for Imparting Conductivity to Nonconductive Polymeric Biomaterials.

  2016cites this paper
• Interstitial Chemotherapy for Malignant Gliomas

  2016cites this paper
• Development of PAC-1 as a privileged agent for combination chemotherapy

  2016cites this paper
• Biodegradable Fatty Acid Polyesters

  2016cites this paper
• Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells

  2015cites this paper
• Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

  2015cites this paper
• Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapy

  2015cites this paper
• Polymeric drug delivery for the treatment of glioblastoma.

  2015cites this paper
• Controlled Release Systems: Brain Tumor Therapy

  2015cites this paper
• Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.

  2015influential citation
• Assessment of drug-loaded nanoparticles in a 3D in vitro brain tumour model

  2015influential citation
• Single compartment drug delivery.

  2014cites this paper
• Focal Controlled Drug Delivery

  2014cites this paper
• Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.

  2014cites this paper
• Treatment of Brain Tumors

  2014cites this paper
• In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil

  2014cites this paper
• The role of Gliadel wafers in the treatment of high-grade gliomas

  2013cites this paper
• Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model

  2013cites this paper
• Novel therapeutic delivery approaches in development for pediatric gliomas.

  2013cites this paper
• Gliadel for brain metastasis

  2013cites this paper
• Évaluation monocentrique de l'implantation de pastilles de carmustine au sein du foyer opératoire de glioblastomes : revue de la littérature : justification du développement de techniques d'infusion convective dans le traitement des gliomes

  2012cites this paper
• The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.

  2012cites this paper
• Novel Delivery Strategies for Glioblastoma

  2012cites this paper
• Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.

  2012cites this paper
• Chemotherapy for brain tumors with polymer drug delivery.

  2012cites this paper
• Drug delivery strategies for the treatment of malignant gliomas.

  2012cites this paper
• An Evidence-based Perspective of Angelica Sinensis (Chinese Angelica) for Cancer Patients

  2011cites this paper
• Modulating macrophage response to biomaterials

  2011cites this paper
• Principles of Chemotherapy

  2011cites this paper
• Determination of effective diffusion coefficients of drug delivery devices by a state observer approach

  2011cites this paper
• Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas.

  2011cites this paper
• Potential approaches for drug delivery to the brain: past, present, and future.

  2010cites this paper
• FasL gene knock-down therapy enhances the antiglioma immune response.

  2010cites this paper
• Medical applications of implantable drug delivery microdevices based on MEMS (Micro-Electro-Mechanical-Systems).

  2010cites this paper
• Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model

  2010cites this paper
• Microcapsule Drug Delivery Device for Treatment MASSACHUSUlTS NStTTE of Glioblastoma Multiforme

  2010cites this paper
• Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells

  2009cites this paper
• Biocompatibility and safety evaluation of a ricinoleic acid-based poly(ester-anhydride) copolymer after implantation in rats.

  2009cites this paper
• CNS drug delivery systems: novel approaches.

  2009cites this paper
• NEUROPROTECTIVE EFFECT OF THYROTROPIN-RELEASING HORMONE (TRH) AGAINST GLUTAMATE TOXICITY IN VITRO

  2009cites this paper
• Hydrogel Matrix Entrapping PLGA-Paclitaxel Microspheres: Drug Delivery with Near Zero-Order Release and Implantability Advantages for Malignant Brain Tumour Chemotherapy

  2009cites this paper
• Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.

  2008cites this paper
• Polyanhydrides as localized drug delivery carrier: an update.

  2008cites this paper
• Chimiotherapie locale dans les gliomes malins : de l'injection ala seringue aux nanotechnologies Local chemotherapy of malignant glioma: From syringe injections to nanotechnology

  2008cites this paper
• Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies

  2008cites this paper
• [Local chemotherapy of malignant glioma: from syringe injections to nanotechnology].

  2008cites this paper
• Reservoir-based devices for the monitoring and treatment of disease

  2008cites this paper
• Polyanhydrides as localized drug delivery carrier: an update

  2008cites this paper
• Xenografts in Athymic Mice and Intracranial Human Glioma and Medulloblastoma-PE 38 ) Treatment of Subcutaneous α Fusion Protein ( TGF-Exotoxin Pseudomonas − − α Transforming Growth Factor-Updated

  2007cites this paper
• Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience

  2007cites this paper
• Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors

  2007cites this paper
• Paclitaxel: a review of adverse toxicities and novel delivery strategies

  2007cites this paper
• Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model

  2007cites this paper
• Interstitial chemotherapy with biodegradable BCNU (Gliadel®) wafers in the treatment of malignant gliomas

  2007influential citation
• Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.

  2007cites this paper